Bioinnovation has the potential to power your business ambition. And we are uniquely placed – with world-class expertise and facilities – to help deliver tangible, valuable commercial advantage.

We innovate at the exciting intersection of biology, engineering and advanced computation… to deliver breakthrough products and services with world-changing significance. Ours is a comprehensive approach founded on three core capabilities – Biostrategy, Biomeasurement and Biomanufacture. 

Biostrategy, Biomeasurement and Biomanufacture

Getting to market as the world transforms

Now more than ever, your route to market must navigate a complex, shifting global landscape. As risks arise, so do the potential rewards. Bioinnovation has the rare capacity to provide clarity and momentum in critical areas of opportunity, such as healthcare, agriculture and climate change. 

Ideas are the easier part; making them a reality is harder. The truth is, you require more than good technology to deliver positive change in a commercial context. To get to market, you need robust, realistic strategies. We can help you develop them because we understand the tools (biotechnology), the rules (governance models) and the interests (economic models) involved. Aligning all three is the secret to business success in Bioinnovation. 

Gaining insight with better information

Bioinnovation relies absolutely on Biomeasurement. It is the bedrock that enables control and optimization. But biological systems are extremely complex, span a huge scale range from km to nm and are incredibly difficult to measure. Success relies on seamless integration across numerous disciplines at which we are adept – including wetware, hardware and software. 

Our unique blend of abilities helps you bring new measurement and diagnosis products to market or integrate new measurement tools into your process and catalyze productivity gains. We understand and develop innovative sensors and cutting-edge data analysis. We’re able to bring together molecular biology, assay development, physics, electronics and AI to achieve the most complex measurements. And we package them for you in robust, easy-to-use, cost-effective solutions that comply with stringent regulatory requirements, including cGMP and medical device quality systems. 

Scaling up and delivering at viable cost

Researchers are continually discovering new ways to apply biology in their pursuit of breakthrough innovation. The real challenge is moving complex processes from the lab to high-volume manufacture at a cost that delivers business viability. Experience tells us that successful scale up demands optimization and invention across all disciplines – including biology, hardware, usability and control systems – plus rigorous regulatory compliance. 

We can help you optimize processes and develop the custom equipment you need to deliver at commercial cost and scale. We work seamlessly across biology, process optimization and equipment design to enable the successful manufacture and delivery of your product or advanced medical therapy. 

Talk to us about world-changing science 

Our experience 

Proven in biodesign 

Our proven biodesign capability has grown organically from our long history in healthcare and life sciences. Few if any of our peers can match our holistic approach which adds biodesign to the complementary disciplines of engineering and computation. This unique breadth of expertise offers significant advantages that speed and ease your path to biomanufacture. 

Antha expertise 

Antha is a programming language for biology. It describes and executes complex workflows, driving massive productivity gains during biodesign. We are long-term partners with Synthace and use Antha in our labs. We can help you discover the power of Antha to unlock your science and gather the data you need without limits.    

Meet the core team

"Biotechnology has the ability to unlock products that improve our lives in ways that have never been possible before." 
Sajith Wimalaratne

Sajith Wimalaratne

"Taking the big picture view, we want to help biotech companies get more products to market, in less time and for lower cost."
Steve Thomas

Steve Thomas

"As a biologist, I love being able to collaborate with colleagues with a vast array of skills and knowledge. Innovation is enabled by the multidisciplinary nature of CC and constantly being asked ‘but why?’ and ‘what else?’. Providing novel solutions to real world problems is very much at the heart of CC."
Frances Jones

Frances Jones

“Biotech has the potential to reshape the global economy and transform every sector in profound ways. Convergence of deep-technologies can enable and accelerate this. Working with our ambitious clients to realise their ideas and discoveries is tremendously rewarding.”
Frances Metcalfe

Frances Metcalfe

"Our clients are diverse, the science they are trying to deliver is novel. Every project brings the opportunity to gain a new understanding." 
Ian Taylor

Tech, tools & facilities

Synthetic biology lab

Synthetic biology labs

Located in our Cambridge head office, our microbiology lab enables us to genetically modify micro-organisms and characterize them. Our facilities are containment level 2 rated for handling pathogenic strains and our in-house libraries allow rapid modular DNA construct design and assembly. We are particularly interested in building organisms that are biological sensors for healthcare and industrial biotech applications.

Life Science Labs

Life science labs

Our suite of restricted Class II laboratories is specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.

Cell culture lab

Cell culture labs

Our life science and synthetic biology facilities are complemented by our recently established cell culture labs. They support our clients in the advanced therapies and pharmaceuticals field to deliver the most advanced drugs on the planet. We’ve equipped them with tools to monitor, grow and store cells which are relevant to cell and gene therapy process development.

Discover the latest in bioinnovation

Case study

CATALOG DNA data encoding machine

May 11, 2020

Enabling the world's first DNA-based platform for massive data storage

  • Bioinnovation
Press release

Rapid discovery and manufacture of next-generation cell therapies

Jan 21, 2020

Kytopen engages Cambridge Consultants to co-develop alpha Flowfect™ System 

  • Bioinnovation
  • Industrial design
  • Product realisation
Press release

Harnessing AI to address global health challenges

Sep 24, 2019

BacillAi is a concept system using AI and low-cost hardware to improve treatment monitoring of TB in resource-limited countries, part of our mission to move AI beyond the hype, addressing practical, global challenges.

  • Bioinnovation
  • Digital health
  • Human factors
  • Mechanical engineering
  • User Experience (UX)
Press release

Cambridge Consultants partners with Hitachi Central Research Laboratory to address the global challenge of plastic waste

Sep 18, 2019

Cambridge Consultants joins the Kyōsō-no-Mori Partnership Program and will work with Hitachi to investigate the applications and business models for applying synthetic biology to plastic recycling.

  • Bioinnovation
  • Physical sciences

Case studies

Waveguide Case Study
Case study

A world first in NMR chemical analysis device productization

Helping a start-up company from breakthrough idea to a world-first device that liberates nuclear magnetic resonance testing from expensive labs to point of care

Better Origin insect larvae rearing

Harnessing the science of synthetic biology and best-in-class automation to turn organic waste into high-protein fish food.

Biology-based contaminant monitoring

Developing biology-based sensors as a cost effective, long-term solution for monitoring environmental public health risks

News & insights

Press release

Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator

Jul 13, 2021

Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices

Press release

Flowfect™ Tx Revealed

Oct 28, 2020

Cambridge Consultants & Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.

What next for smart implantable medical devices?
Opinion

What next for smart implants?

Feb 20, 2023

The future of smart implantable medical devices – Our experts share key insights for medical implant manufacturers.

  • AI & Analytics
  • Bioinnovation
  • Digital health
The race for success in home monitoring
Opinion

What is the key to successful ophthalmology home monitoring?

Jun 28, 2023

The digital future of ophthalmology comes with the promise of improved patient access, better quality of care, reduced workloads, optimized efficiencies and improved quality of life for patients and HCPs. There are many challenges to be overcome, not least the need to develop data, workflows and technologies in tandem. One example core example is how to best unlock successful home monitoring for ophthalmology…

  • Bioinnovation
  • Digital health